Please login to the form below
Hybrigenics appoints Dr Alain Munoz
France-based bio-pharmaceutical company Hybrigenics has appointed Dr Alain Munoz to its board of directors
France-based bio-pharmaceutical company Hybrigenics has appointed Dr Alain Munoz to its board of directors.
Dr Munoz replaces Dr Bernhard Ehmer, president of ImClone Systems, and will chair the clinical advisory board.
He has over 20 years' experience in the pharmaceutical industry at senior management level with the Sanofi Group as R&D vice-president and the French pharmaceutical company Fournier as VP of R&D and business development, subsequently becoming senior VP of the pharmaceutical division.
As well as his position at Hybrigenics, Dr Munoz is also a board member of several biotechnology companies including Novagali Pharma and Zealand Pharma.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Manager
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Manager (PR)
-
Great Benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Senior External Communications Lead
-
£Competitive Salary
- Sanofi doses first patient in global Kevzara COVID-19 trial
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- MHRA raises concerns over fraudulent coronavirus tests
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
- Novartis donates malaria drug for COVID-19 clinical trials
- Servier agrees to buy Symphogen to swell its cancer pipeline
- A Renewed Love of the NHS and National Recovery of the Patient-Doctor Relationship
- GSK and Vir Biotech join forces for COVID-19 antibodies
- Coronavirus causes Cancer Research UK to slash funding by £44m
- EMA backs compassionate use of Gilead’s remdesivir for COVID-19
- Nurses on the frontline – World Health Day 2020
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- What challenges still face clinical trial recruitment and retention?
- Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Quick links
Infographics
